FDA chief has no 'plans' for abortion pill policy changes but continues safety review
"We have an ongoing review of safety data on mifepristone, which is a requirement from the prior administrations," Makary said in an interview with POLITICO. "You always have to be open-minded. You have to listen to different opinions and make decisions based on what you think is the right thing to do."
His comments mirror those he made during the Semafor World Economy Summit in April.
During the summit, Makary said he has "no plans to take action" that would restrict the abortion drug's availability, but cautioned the agency wouldn't hesitate to act if the data suggested there was a safety issue.
"There is an ongoing set of data that is coming into the FDA on mifepristone," he said. "So if the data suggests something or tells us that there's a real signal, we can't promise we're not going to act on that data."
Sen. Josh Hawley, R-Mo., wrote an April 28 letter to Makary regarding safety concerns about mifepristone.
"I urge you to follow this new data and take all appropriate action to restore critical safeguards on the use of mifepristone. The health and safety of American women depend on it," Hawley wrote.
Makary said during the interview with POLITICO that he has no plans to make "any changes" with policy regarding mifepristone, adding he would "continue to listen to folks that say they have concerns."
Fox News Digital reached out to the FDA and Sen. Hawley for comment.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 minutes ago
- Yahoo
The White House just got another useless gold ornament.
Billionaire Apple CEO Tim Cook presented Donald Trump with a gaudy personalized gift boasting a 24-karat gold base as the tech giant woo'ed the president at the White House on Wednesday. Cook dropped in to the White House bearing his golden gift to announce the tech company's extra $100 billion investment in American manufacturing as the president still waves the threat of tariffs. The president started the press conference by calling Cook, 'One of the great and most esteemed business leaders and geniuses and innovators anywhere in the world.'
Yahoo
3 minutes ago
- Yahoo
Becton, Dickinson and Company Submits Application to the FDA for a New, At-Home HPV Test
Becton, Dickinson and Company (NYSE:BDX) is one of the . On July 31, Becton, Dickinson and Company (NYSE:BDX) announced that it submitted an application to the U.S. FDA for a new, at-home HPV test. The new HPV test focuses on patients to self-collect a sample at their home using a swab, the size of a Q-tip, simplifying lab processing. According to BD, this method also reports more high-risk strains of HPV compared to other tests on the market today. A person wearing a state-of-the-art medical device for nerve conduction tests. 'We envision a world where women are empowered with access and a choice for their HPV screening, whether it be in a routine visit at the doctor's office or the comfort and privacy of their own home via a self-collected sample. Cervical cancer and the loss of more than 4,000 women per year to this devastating disease is preventable, and we believe at-home testing is an important leap forward to our goal of eliminating this type of cancer,' said Nikos Pavlidis, president of BD Diagnostic Solutions. BD's new HPV test will include a state-of-the-art self-collection swab technology that also offers convenient mailing from home to the lab, supporting broader participation in cervical cancer screening programs. The self-collected swab requires no manual sample preparation by clinical laboratory technologists. This process will allow them to focus on higher-value work. Becton, Dickinson and Company (NYSE:BDX) is a global medical technology company that focuses on the development, manufacturing, and sale of various medical supplies, devices, diagnostic products, and laboratory equipment. While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey. Sign in to access your portfolio
Yahoo
3 minutes ago
- Yahoo
Trump increases India tariffs to 50% for buying Russian oil
US President Donald Trump on Wednesday signed an executive order to impose an additional 25 percent tariff on India over its purchase of Russian oil, bringing the total duties on the energy-starved country to 50 percent as Trump attempts to force an end to Russia's war in Ukraine.
